Meeder Asset Management’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-783
Closed -$165K 955
2024
Q3
$165K Buy
+783
New +$136K 0.01% 237
2023
Q3
Sell
-3,921
Closed -$1.27M 536
2023
Q2
$1.27M Buy
3,921
+3,864
+6,779% +$1.1M 0.09% 149
2023
Q1
$13.3K Sell
57
-102
-64% -$25.8K ﹤0.01% 490
2022
Q4
$40K Buy
159
+157
+7,850% +$33.5K ﹤0.01% 544
2022
Q3
$0 Buy
+2
New +$402 ﹤0.01% 2241
2020
Q2
Sell
-62
Closed -$4K 2246
2020
Q1
$4K Buy
+62
New +$4.59K ﹤0.01% 1865

Other funds holding INSP

Meeder Asset Management's INSP Position: Q4 2024 in Review

Meeder Asset Management sold out of Inspire Medical Systems (INSP) in Q4 2024, closing a stake of 783 shares — an estimated $165K sold.

Meeder Asset Management first reported a position in INSP in Q1 2020 and held it in 6 quarters. The position peaked at $1.27M in Q2 2023. 357 funds tracked by Wall St. Rank hold INSP as of Q4 2024.

  • Meeder Asset Management reported no remaining Inspire Medical Systems position as of Q4 2024 after selling out during the quarter.
  • Meeder Asset Management sold 783 Inspire Medical Systems shares in Q4 2024, an estimated $165K.
  • Meeder Asset Management first reported a position in Inspire Medical Systems in Q1 2020 and held it in 6 quarters.
  • Meeder Asset Management's Inspire Medical Systems position peaked at $1.27M in Q2 2023.
  • 357 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q4 2024.

Based on Meeder Asset Management's 13F filing for Q4 2024, filed 12 Feb 2025.